Research Laboratories

Our research is focused on understanding bacterial biofilm infection, especially skin and wound infection. Specifically, we study microbiomes of wounds, including chronic wounds. Our research has also expanded into the field of antimicrobial peptides that target skin and wound infection. This is crucial early-stage research aimed at developing novel antibiofilm therapies.

Our laboratory is located in the Interdisciplinary Stem Cell Institute. We are primarily focused on translational research of stem cells and stem cell products in wound healing, burn injury, inherited dermatoses as well as skin and systemic inflammatory disorders.

Our research uses a three-pronged approach to understand how the immune system modulates stress responses and susceptibility to depression.

Glia are the most abundant cell type in the nervous system. Until recently, glia were thought to be mere support cells for neurons with no active role in processing and propagating synaptic information.

Our overall mission is to identify the impact of hearing loss and parenting behaviors on children’s cognitive, behavioral and social/emotional development.

The Chaudhari lab studies cellular physiology of the taste system in the peripheral detectors, the taste buds, and in the sensory neurons that innervate them. We use a variety of tools – from single-cell RNA sequencing, to confocal microscopy, to in vivo Ca2+ imaging in anesthetized mice.

Our group genetically engineers living cells and proteins for environmental detection, molecular sensing, molecular diagnostics, point-of-care tests, biomarker identification, and drug delivery. Additionally, the research of the group focuses on the development of targeted and responsive drug delivery systems.

The Davis laboratory has extensive experience and expertise in the evaluation of wound healing agents using various in vitro and in vivo preclinical models.

We are a bionanotechnology research lab in the Biochemistry & Molecular Biology Department of the University of Miami Miller School of Medicine located in Miami, Florida. We develop novel biotechnology tools employing luminescent proteins and inorganic probes.

Dr. Dhar’s team develop macromolecular technologies, which are engineered to nanoparticles and targeted to the mitochondria of cells and they have chemistry-based programs on combination therapy for various cancers.

The main lines of research in the Domínguez-Bendala Lab revolve around the development of regenerative strategies for type 1 diabetes, including stem cell differentiation into insulin-producing β-cells and islet regeneration.

The Farkas lab is dedicated to understanding and addressing neurogenic obesity and its associated endometabolic complications in individuals with spinal cord injury (SCI)

The Goldberg Lab uses tools from epidemiology, biostatistics, health services research, and empirical bioethics to study and improve outcomes among patients with chronic liver disease and cirrhosis, patients pre- and post-liver transplantation, and the broader population of patients waitlisted for a solid organ transplant.

Our research focuses on bio-behavioral interventions that promote HIV risk reduction and treatment adherence in sub-Saharan Africa, South America, India, and the U.S. We’re working to discover the various factors that influence optimal health outcomes in people living with HIV.

The primary goal of our laboratory is to understand the role caveolins and caveolae play in cutaneous physiology and pathophysiology.

Dr. Lassance-Soares’ Lab studies cellular and molecular mechanism underlying neovascularization and endothelial dysfunction, with a strong focus in translational research. Specifically, Dr. Lassance-Soares interest is to enhance angiogenesis and arteriogenesis in pre-clinical model of hindlimb ischemia.

The central project in our laboratory is currently the investigation of the molecular machine, which releases many neurotransmitters and hormones in the body.

The molecular and cellular biology of the bactericidal pore-forming protein Perforin-2 (MPEG1) is a major area of emphasis within the Munson laboratory. Concurrently we are using multidisciplinary approaches to discover and characterize bacterial effectors that subvert or inhibit the bactericidal activity of Perforin-2 with a particular emphasis on enteric and multidrug resistant pathogens.

Dr. Pahwa’s expertise is in Immunology with a focus on immune development and HIV immunopathogenesis across the life span from childhood to aging.

Pastar’s lab within the Wound Healing and Regenerative Medicine Research Program focuses on molecular mechanisms of wound infections and host-pathogen interaction in the context of cutaneous wound healing.

Dr. Pastori’s overall research interests focus on the development of translational molecular strategies for the advancement of type 1 diabetes treatments, including regenerative approaches for pancreatic islets and beta-cells.

Dr Paus’ laboratory focuses on the biology and pathology of human hair follicles, covering a wide range of topics from hair growth control, pigmentation, neuroendocrinology, neurobiology and immunology of the hair follicle via the pathobiology of alopecia areata, lichen planopilaris, and frontal fibrosing alopecia to novel management strategies for chemotherapy-induced alopecia and hair graying.

The goal of the Starke laboratory is to study cerebrovascular diseases from a clinical, translational, therapeutic, and basic science prospective. Our laboratory is uniquely suited to investigate cerebrovascular disease using a multipronged approach consisting of cell culture, experimental aneurysm models, advanced imaging modalities and clinical studies.

Translational genomics (Skinomics), skin fibrosis, chronic wound healing, precision medicine.

The main research interest in my laboratory is focused on the vascular effects of HIV infection with the focus on the alterations of the blood-brain barrier (BBB).

The Tuesta Lab is interested in understanding the epigenetic mechanisms underpinning activation of microglia and how persistent activation of these cells by chemotherapeutic agents can drive cognitive and attentional deficits in cancer patients receiving chemotherapy.

Welcome to the University of Miami Thyroid Study Unit, a leading research facility dedicated to the clinical and laboratory investigation of inherited and rare thyroid disorders. Our mission is to advance understanding, diagnosis, and treatment in this field through both clinical studies and basic science research.

Our research focuses on neurological disease and its underlying causes to develop promising new therapies. We create induced pluripotent stem cells (iPSCs) — which allow us to study human neurons — to model neurodevelopmental and neurodegenerative diseases using 2D neuronal cultures and 3D cerebral brain organoids. This enables us to investigate how specific mutations lead to these diseases.